Published Medical Influenza Drug This technology uses two molecular compounds, ASN-D and LAS-T, that effectively bind to viral replication machinery inside infected cells and prevent the virus from spreading. By Brigham Young University
Published Healthcare & Pharmaceuticals Universal Influenza Vaccine This technology is a layered nanoparticle vaccine designed to be highly effective against both influenza A and B strains. By Georgia State University
Do you have an innovative technology, product or service? Add your solution to the world’s most advanced open innovation platform and get seen by global corporations seeking new solutions – all free of charge.
Published New TMPRSS2 inhibitors as antivirals for coronavirus and influenza pandemics Potent and specific small molecule inhibitors for the human transmembrane serine protease TMPRSS2. By Yasmina ZEROUAL, University of Liège
Share your thoughts, insights and tips Join thousands of like-minded individuals from across the globe to share your insight on fresh innovative topics by posting articles.
